Israel’s Allium Ltd. won the European CE mark for the company’s triangular prostatic stent for patients with benign prostatic hyperplasia (BPH) or with advanced prostate cancer.
From the product page:
Allium’s prostatic stents have a large caliber triangular cross-section to match the contours of the prostatic urethral lumen and have the ability to exert varying degrees of radial force depending on the anatomy. For example, higher radial force in its main body and lower radial force in the area near the external sphincter to prevent sphincteric dysfunction. These characteristics enable the Allium Prostatic Stents to conform to the prostatic urethra, allow an excellent flow and offer a much improved comfort than existing stents, all these without geopardizing the voluntary continence mechanism.